Global Insulin Market Growth 2022-2028
As the global economy mends, the 2021 growth of Insulin will have significant change from previous year. According to our latest study, the global Insulin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Insulin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Insulin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Insulin market, reaching US$ million by the year 2028. As for the Europe Insulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Insulin players cover Novo Nordisk, Eli Lilly, Sanofi-Aventis, and Tonghua Dongbao, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Insulin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Insulin by Country/Region, 2017, 2022 & 2028
2.2 Insulin Segment by Type
2.2.1 Animal Insulin
2.2.2 Regular Human Insulin
2.2.3 Insulin Analogue
2.3 Insulin Sales by Type
2.3.1 Global Insulin Sales Market Share by Type (2017-2022)
2.3.2 Global Insulin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Insulin Sale Price by Type (2017-2022)
2.4 Insulin Segment by Application
2.4.1 Short Acting
2.4.2 Intermediate Acting
2.4.3 Long Acting
2.4.4 Pre-Mix Insulin
2.5 Insulin Sales by Application
2.5.1 Global Insulin Sale Market Share by Application (2017-2022)
2.5.2 Global Insulin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Insulin Sale Price by Application (2017-2022)
3 Global Insulin by Company
3.1 Global Insulin Breakdown Data by Company
3.1.1 Global Insulin Annual Sales by Company (2020-2022)
3.1.2 Global Insulin Sales Market Share by Company (2020-2022)
3.2 Global Insulin Annual Revenue by Company (2020-2022)
3.2.1 Global Insulin Revenue by Company (2020-2022)
3.2.2 Global Insulin Revenue Market Share by Company (2020-2022)
3.3 Global Insulin Sale Price by Company
3.4 Key Manufacturers Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Product Location Distribution
3.4.2 Players Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insulin by Geographic Region
4.1 World Historic Insulin Market Size by Geographic Region (2017-2022)
4.1.1 Global Insulin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Insulin Annual Revenue by Geographic Region
4.2 World Historic Insulin Market Size by Country/Region (2017-2022)
4.2.1 Global Insulin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Insulin Annual Revenue by Country/Region
4.3 Americas Insulin Sales Growth
4.4 APAC Insulin Sales Growth
4.5 Europe Insulin Sales Growth
4.6 Middle East & Africa Insulin Sales Growth
5 Americas
5.1 Americas Insulin Sales by Country
5.1.1 Americas Insulin Sales by Country (2017-2022)
5.1.2 Americas Insulin Revenue by Country (2017-2022)
5.2 Americas Insulin Sales by Type
5.3 Americas Insulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Sales by Region
6.1.1 APAC Insulin Sales by Region (2017-2022)
6.1.2 APAC Insulin Revenue by Region (2017-2022)
6.2 APAC Insulin Sales by Type
6.3 APAC Insulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin by Country
7.1.1 Europe Insulin Sales by Country (2017-2022)
7.1.2 Europe Insulin Revenue by Country (2017-2022)
7.2 Europe Insulin Sales by Type
7.3 Europe Insulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin by Country
8.1.1 Middle East & Africa Insulin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Insulin Revenue by Country (2017-2022)
8.2 Middle East & Africa Insulin Sales by Type
8.3 Middle East & Africa Insulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin
10.3 Manufacturing Process Analysis of Insulin
10.4 Industry Chain Structure of Insulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Distributors
11.3 Insulin Customer
12 World Forecast Review for Insulin by Geographic Region
12.1 Global Insulin Market Size Forecast by Region
12.1.1 Global Insulin Forecast by Region (2023-2028)
12.1.2 Global Insulin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insulin Forecast by Type
12.7 Global Insulin Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Insulin Product Offered
13.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Insulin Product Offered
13.2.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Sanofi-Aventis
13.3.1 Sanofi-Aventis Company Information
13.3.2 Sanofi-Aventis Insulin Product Offered
13.3.3 Sanofi-Aventis Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi-Aventis Main Business Overview
13.3.5 Sanofi-Aventis Latest Developments
13.4 Tonghua Dongbao
13.4.1 Tonghua Dongbao Company Information
13.4.2 Tonghua Dongbao Insulin Product Offered
13.4.3 Tonghua Dongbao Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Tonghua Dongbao Main Business Overview
13.4.5 Tonghua Dongbao Latest Developments
13.5 Ganlee
13.5.1 Ganlee Company Information
13.5.2 Ganlee Insulin Product Offered
13.5.3 Ganlee Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ganlee Main Business Overview
13.5.5 Ganlee Latest Developments
13.6 United Laboratory
13.6.1 United Laboratory Company Information
13.6.2 United Laboratory Insulin Product Offered
13.6.3 United Laboratory Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 United Laboratory Main Business Overview
13.6.5 United Laboratory Latest Developments
13.7 Jiangsu Wanbang
13.7.1 Jiangsu Wanbang Company Information
13.7.2 Jiangsu Wanbang Insulin Product Offered
13.7.3 Jiangsu Wanbang Insulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Jiangsu Wanbang Main Business Overview
13.7.5 Jiangsu Wanbang Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Insulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Insulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Animal Insulin
Table 4. Major Players of Regular Human Insulin
Table 5. Major Players of Insulin Analogue
Table 6. Global Insulin Sales by Type (2017-2022) & (M Pcs)
Table 7. Global Insulin Sales Market Share by Type (2017-2022)
Table 8. Global Insulin Revenue by Type (2017-2022) & ($ million)
Table 9. Global Insulin Revenue Market Share by Type (2017-2022)
Table 10. Global Insulin Sale Price by Type (2017-2022) & (US$/Pcs)
Table 11. Global Insulin Sales by Application (2017-2022) & (M Pcs)
Table 12. Global Insulin Sales Market Share by Application (2017-2022)
Table 13. Global Insulin Revenue by Application (2017-2022)
Table 14. Global Insulin Revenue Market Share by Application (2017-2022)
Table 15. Global Insulin Sale Price by Application (2017-2022) & (US$/Pcs)
Table 16. Global Insulin Sales by Company (2020-2022) & (M Pcs)
Table 17. Global Insulin Sales Market Share by Company (2020-2022)
Table 18. Global Insulin Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Insulin Revenue Market Share by Company (2020-2022)
Table 20. Global Insulin Sale Price by Company (2020-2022) & (US$/Pcs)
Table 21. Key Manufacturers Insulin Producing Area Distribution and Sales Area
Table 22. Players Insulin Products Offered
Table 23. Insulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Insulin Sales by Geographic Region (2017-2022) & (M Pcs)
Table 27. Global Insulin Sales Market Share Geographic Region (2017-2022)
Table 28. Global Insulin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Insulin Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Insulin Sales by Country/Region (2017-2022) & (M Pcs)
Table 31. Global Insulin Sales Market Share by Country/Region (2017-2022)
Table 32. Global Insulin Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Insulin Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Insulin Sales by Country (2017-2022) & (M Pcs)
Table 35. Americas Insulin Sales Market Share by Country (2017-2022)
Table 36. Americas Insulin Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Insulin Revenue Market Share by Country (2017-2022)
Table 38. Americas Insulin Sales by Type (2017-2022) & (M Pcs)
Table 39. Americas Insulin Sales Market Share by Type (2017-2022)
Table 40. Americas Insulin Sales by Application (2017-2022) & (M Pcs)
Table 41. Americas Insulin Sales Market Share by Application (2017-2022)
Table 42. APAC Insulin Sales by Region (2017-2022) & (M Pcs)
Table 43. APAC Insulin Sales Market Share by Region (2017-2022)
Table 44. APAC Insulin Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Insulin Revenue Market Share by Region (2017-2022)
Table 46. APAC Insulin Sales by Type (2017-2022) & (M Pcs)
Table 47. APAC Insulin Sales Market Share by Type (2017-2022)
Table 48. APAC Insulin Sales by Application (2017-2022) & (M Pcs)
Table 49. APAC Insulin Sales Market Share by Application (2017-2022)
Table 50. Europe Insulin Sales by Country (2017-2022) & (M Pcs)
Table 51. Europe Insulin Sales Market Share by Country (2017-2022)
Table 52. Europe Insulin Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Insulin Revenue Market Share by Country (2017-2022)
Table 54. Europe Insulin Sales by Type (2017-2022) & (M Pcs)
Table 55. Europe Insulin Sales Market Share by Type (2017-2022)
Table 56. Europe Insulin Sales by Application (2017-2022) & (M Pcs)
Table 57. Europe Insulin Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Insulin Sales by Country (2017-2022) & (M Pcs)
Table 59. Middle East & Africa Insulin Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Insulin Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Insulin Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Insulin Sales by Type (2017-2022) & (M Pcs)
Table 63. Middle East & Africa Insulin Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Insulin Sales by Application (2017-2022) & (M Pcs)
Table 65. Middle East & Africa Insulin Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Insulin
Table 67. Key Market Challenges & Risks of Insulin
Table 68. Key Industry Trends of Insulin
Table 69. Insulin Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Insulin Distributors List
Table 72. Insulin Customer List
Table 73. Global Insulin Sales Forecast by Region (2023-2028) & (M Pcs)
Table 74. Global Insulin Sales Market Forecast by Region
Table 75. Global Insulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Insulin Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Insulin Sales Forecast by Country (2023-2028) & (M Pcs)
Table 78. Americas Insulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Insulin Sales Forecast by Region (2023-2028) & (M Pcs)
Table 80. APAC Insulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Insulin Sales Forecast by Country (2023-2028) & (M Pcs)
Table 82. Europe Insulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Insulin Sales Forecast by Country (2023-2028) & (M Pcs)
Table 84. Middle East & Africa Insulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Insulin Sales Forecast by Type (2023-2028) & (M Pcs)
Table 86. Global Insulin Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Insulin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Insulin Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Insulin Sales Forecast by Application (2023-2028) & (M Pcs)
Table 90. Global Insulin Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Insulin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Insulin Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novo Nordisk Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Novo Nordisk Insulin Product Offered
Table 95. Novo Nordisk Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 96. Novo Nordisk Main Business
Table 97. Novo Nordisk Latest Developments
Table 98. Eli Lilly Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly Insulin Product Offered
Table 100. Eli Lilly Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Latest Developments
Table 103. Sanofi-Aventis Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi-Aventis Insulin Product Offered
Table 105. Sanofi-Aventis Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 106. Sanofi-Aventis Main Business
Table 107. Sanofi-Aventis Latest Developments
Table 108. Tonghua Dongbao Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Tonghua Dongbao Insulin Product Offered
Table 110. Tonghua Dongbao Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 111. Tonghua Dongbao Main Business
Table 112. Tonghua Dongbao Latest Developments
Table 113. Ganlee Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Ganlee Insulin Product Offered
Table 115. Ganlee Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 116. Ganlee Main Business
Table 117. Ganlee Latest Developments
Table 118. United Laboratory Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 119. United Laboratory Insulin Product Offered
Table 120. United Laboratory Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 121. United Laboratory Main Business
Table 122. United Laboratory Latest Developments
Table 123. Jiangsu Wanbang Basic Information, Insulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Wanbang Insulin Product Offered
Table 125. Jiangsu Wanbang Insulin Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 126. Jiangsu Wanbang Main Business
Table 127. Jiangsu Wanbang Latest Developments
List of Figures
Figure 1. Picture of Insulin
Figure 2. Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Sales Growth Rate 2017-2028 (M Pcs)
Figure 7. Global Insulin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Insulin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Animal Insulin
Figure 10. Product Picture of Regular Human Insulin
Figure 11. Product Picture of Insulin Analogue
Figure 12. Global Insulin Sales Market Share by Type in 2021
Figure 13. Global Insulin Revenue Market Share by Type (2017-2022)
Figure 14. Insulin Consumed in Short Acting
Figure 15. Global Insulin Market: Short Acting (2017-2022) & (M Pcs)
Figure 16. Insulin Consumed in Intermediate Acting
Figure 17. Global Insulin Market: Intermediate Acting (2017-2022) & (M Pcs)
Figure 18. Insulin Consumed in Long Acting
Figure 19. Global Insulin Market: Long Acting (2017-2022) & (M Pcs)
Figure 20. Insulin Consumed in Pre-Mix Insulin
Figure 21. Global Insulin Market: Pre-Mix Insulin (2017-2022) & (M Pcs)
Figure 22. Global Insulin Sales Market Share by Application (2017-2022)
Figure 23. Global Insulin Revenue Market Share by Application in 2021
Figure 24. Insulin Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Insulin Revenue Market Share by Company in 2021
Figure 26. Global Insulin Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Insulin Revenue Market Share by Geographic Region in 2021
Figure 28. Global Insulin Sales Market Share by Region (2017-2022)
Figure 29. Global Insulin Revenue Market Share by Country/Region in 2021
Figure 30. Americas Insulin Sales 2017-2022 (M Pcs)
Figure 31. Americas Insulin Revenue 2017-2022 ($ Millions)
Figure 32. APAC Insulin Sales 2017-2022 (M Pcs)
Figure 33. APAC Insulin Revenue 2017-2022 ($ Millions)
Figure 34. Europe Insulin Sales 2017-2022 (M Pcs)
Figure 35. Europe Insulin Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Insulin Sales 2017-2022 (M Pcs)
Figure 37. Middle East & Africa Insulin Revenue 2017-2022 ($ Millions)
Figure 38. Americas Insulin Sales Market Share by Country in 2021
Figure 39. Americas Insulin Revenue Market Share by Country in 2021
Figure 40. United States Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Insulin Sales Market Share by Region in 2021
Figure 45. APAC Insulin Revenue Market Share by Regions in 2021
Figure 46. China Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Insulin Sales Market Share by Country in 2021
Figure 53. Europe Insulin Revenue Market Share by Country in 2021
Figure 54. Germany Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Insulin Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Insulin Revenue Market Share by Country in 2021
Figure 61. Egypt Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Insulin Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Insulin in 2021
Figure 67. Manufacturing Process Analysis of Insulin
Figure 68. Industry Chain Structure of Insulin
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
